Qsight has been monitoring the Axonics F15 SNM System since its launch in March 2022. Our healthcare facilities dataset shows that Axonics experienced a rapid increase in sales after the launch of this system, as this system offers a recharge-free option that now directly competes with Medtronic’s Interstim X.

As 2023 began with lingering economic concerns from 2022 (inflation, rising interest rates, risk of recession, etc.), the aesthetics industry’s hope for continued strong growth may be challenged.

With the leader of the TAVR market, Edwards Lifesciences, reporting a small miss in their third quarter earnings report, Guidepoint Qsight analyzed the short term and long-term effects of COVID-19 on the overall U.S. TAVR market.

Qsight’s HME/DME Purchasing Data provides clients with real-time intelligence into market share and purchasing insights in the non-acute medical device sector. We looked at our capture of insulin pumps from the top players to assess market share and market growth in the durable medical equipment channel.

Guidepoint Qsight’s healthcare facilities purchasing dataset captures trends in multiple segments within the MedTech space. We break down insights on these segments and the top manufacturers in the space.

As MedSpas become an important growth driver for the medical aesthetics industry in the U.S., Qsight’s aesthetics point-of-sale data...

With Abbott announcing the availability of its Amplatzer Steerable Delivery Sheath, Guidepoint Qsight took a closer look at the left atrial appendage closure market...